Cardiff Oncology, Inc.CRDFNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank93
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.77
↑ 95% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-16.00
Historical baseline
PeriodValueYoY Change
TTM-0.77+18.9%
2024-0.95-2.2%
2023-0.93-4.5%
2022-0.89-21.9%
2021-0.73+32.4%
2020-1.08+60.0%
2019-2.70+61.8%
2018-7.06+86.3%
2017-51.71+44.5%
2016-93.22-